Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs

D. Smajs, J. Bureš, J. Smarda, E. Chaloupková, J. Květina, M. Förstl, D. Kohoutová, M. Kuneš, S. Rejchrt, J. Lesná, M. Kopáčová,

. 2012 ; 64 (3) : 205-10.

Language English Country United States

Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't

Grant support
NS9665 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK ProQuest Central from 1997-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-01-01 to 1 year ago

The strain Escherichia coli Nissle 1917 (EcN) is widely used as an efficient probiotic in therapy and prevention of human infectious diseases, especially of the intestinal system. Concurrently, small adult pigs are being used as experimental omnivore models to study human gastrointestinal functions. EcN bacteria were applied to 6 adult healthy female pigs in a 2-week trial. 6 Control animals remained untreated. Altogether, 164 and 149 bacterial strains were isolated from smear samples taken from gastrointestinal mucosa in the experimental and control group, respectively. Each individual E. coli strain was then tested for the presence of 29 bacteriocin-encoding determinants as well as for DNA markers of A, B1, B2 and D phylogenetic groups. A profound reduction of E. coli genetic variance (from 32 variants to 13 ones, P = 0.0006) was found in the experimental group, accompanied by a lower incidence of bacteriocin producers in the experimental group when compared to control (21.3 and 34.9%, respectively; P = 0.007) and by changes in the incidence of individual bacteriocin types. The experimental administration of EcN strain was not sufficient for stable colonization of porcine gut, but induced significant changes in the enterobacterial microbiota.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024245
003      
CZ-PrNML
005      
20170621101626.0
007      
ta
008      
120815s2012 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1007/s00284-011-0051-x $2 doi
035    __
$a (PubMed)22116501
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Smajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, Czech Republic. dsmajs@med.muni.cz
245    10
$a Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs / $c D. Smajs, J. Bureš, J. Smarda, E. Chaloupková, J. Květina, M. Förstl, D. Kohoutová, M. Kuneš, S. Rejchrt, J. Lesná, M. Kopáčová,
520    9_
$a The strain Escherichia coli Nissle 1917 (EcN) is widely used as an efficient probiotic in therapy and prevention of human infectious diseases, especially of the intestinal system. Concurrently, small adult pigs are being used as experimental omnivore models to study human gastrointestinal functions. EcN bacteria were applied to 6 adult healthy female pigs in a 2-week trial. 6 Control animals remained untreated. Altogether, 164 and 149 bacterial strains were isolated from smear samples taken from gastrointestinal mucosa in the experimental and control group, respectively. Each individual E. coli strain was then tested for the presence of 29 bacteriocin-encoding determinants as well as for DNA markers of A, B1, B2 and D phylogenetic groups. A profound reduction of E. coli genetic variance (from 32 variants to 13 ones, P = 0.0006) was found in the experimental group, accompanied by a lower incidence of bacteriocin producers in the experimental group when compared to control (21.3 and 34.9%, respectively; P = 0.007) and by changes in the incidence of individual bacteriocin types. The experimental administration of EcN strain was not sufficient for stable colonization of porcine gut, but induced significant changes in the enterobacterial microbiota.
650    _2
$a zvířata $7 D000818
650    _2
$a bakteriociny $x genetika $7 D001430
650    _2
$a společenstvo $7 D058448
650    _2
$a Escherichia coli $x klasifikace $x izolace a purifikace $7 D004926
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a bakteriální geny $7 D005798
650    _2
$a genetická variace $7 D014644
650    _2
$a střevní sliznice $x mikrobiologie $7 D007413
650    _2
$a molekulární typizace $7 D058889
650    _2
$a fylogeneze $7 D010802
650    _2
$a probiotika $x aplikace a dávkování $7 D019936
650    _2
$a prasata $7 D013552
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bureš, Jan
700    1_
$a Smarda, Jan
700    1_
$a Chaloupková, Eva
700    1_
$a Květina, Jaroslav
700    1_
$a Förstl, Miroslav
700    1_
$a Kohoutová, Darina
700    1_
$a Kuneš, Martin $7 xx0081968
700    1_
$a Rejchrt, Stanislav
700    1_
$a Lesná, Jiřina
700    1_
$a Kopáčová, Marcela, $d 1959- $7 xx0032944
773    0_
$w MED00001275 $t Current microbiology $x 1432-0991 $g Roč. 64, č. 3 (2012), s. 205-10
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22116501 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120815 $b ABA008
991    __
$a 20170621102045 $b ABA008
999    __
$a ok $b bmc $g 946393 $s 781573
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 64 $c 3 $d 205-10 $i 1432-0991 $m Current microbiology $n Curr Microbiol $x MED00001275
GRA    __
$a NS9665 $p MZ0
LZP    __
$a Pubmed-20120815/12/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...